SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-034938
Filing Date
2023-06-07
Accepted
2023-06-07 11:00:06
Documents
2
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1536
2 POA DOCUMENT poa.txt EX-24 2940
  Complete submission text file 0001209191-23-034938.txt   6131
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Issuer) CIK: 0000879169 (see all company filings)

IRS No.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
CAGNONI PABLO J (Reporting) CIK: 0001205703 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12400 | Film No.: 23998105